Cancer cases today reach senior oncologists fragmented — records across three centres, biomarkers buried in long PDFs, treatment chronologies that exist only in the patient's memory. By the time the case reaches a sub-specialist, much of the consultation is record-reading, not decision-making. And the patient often arrives at the wrong sub-specialty for their actual case.
The Brown Sage is a navigation intelligence layer — what we call Cancer Care GPS. We structure the case before it reaches you. We route by clinical relevance, not by who is online. We pay fairly and on time. And we do not take referral commissions — ever.
The founding panel is being assembled deliberately — small, peer-led, and TMH-anchored. The first 50 active Founding Specialists will shape how the platform routes, scores, and reviews cases for the decade ahead.
A case lands in your queue only when DMG, stage, biomarker, treatment history, and your declared sub-specialty focus all align. You see the case context, the matchmaking rationale, and the patient's prepared questions before you begin.
The case arrives as a structured clinical view — diagnosis, stage, pathology, biomarkers, chronology, active flags, pending workup, patient's questions. Every value is traceable to its source. Full source documents available on tap.
A single free-text window. No fixed template. You write the opinion in the format you are most comfortable with — your judgement, your voice. Submit when ready.
Transferred directly within 7 days of opinion delivery — at the pre-agreed per-case fee. You receive the full amount; no deductions at our end. Clean, simple, on time.
Patient records are encrypted in transit (TLS 1.3) and at rest (AES-256). Patient consent captured before any record reaches a specialist. Per-case audit trail. The right to withdraw consent is built into the platform. Breach notification protocols in place.
Your NMC registration number displayed on every opinion you issue. Records retained for 3 years per regulation. Scope of opinion clearly stated. Patient told that the opinion is for consultation with their primary treating clinician — not a replacement for it.
You provide a written second opinion based on documented records — not primary care, not a doctor-patient relationship in the full clinical sense. The same liability framework used internationally by 2nd.MD, Cleveland Clinic, and MORE Health, and in India by Navya. The full framework document is available to review at the point of empanelment.
Most senior oncologists who reach this page want to see how a real case actually moves through the platform — from a patient's uploaded records, through the Clinical Intelligence and Matchmaking layers, to the structured view that arrives in your queue. The walkthrough is best experienced live, with Dr Pritesh, calibrated to your sub-specialty and your questions.
A short, focused conversation. Most of what a 15-minute call would cover is covered here — but with your case-mix, your concerns, your clinical context as the frame.
Walked through a real case — yours, or one I bring. Calibrated to your sub-specialty. Your questions answered in the moment.
A patient can upload records to a general AI tool; many already do. The structural difference is what arrives on your desk, and what has been done to it before it gets there.
Source-linked, not chat-generated.
Every extracted field carries its source quote and source document. Every field is tagged with confidence (high / medium / low) and extraction status (confirmed / inferred). A general AI tool produces confident text regardless of whether the underlying signal is solid; this system surfaces the signal-strength of every value explicitly.
Conflict-resolved, not silently blended.
Case fusion across multiple documents applies explicit source priority by document type (pathology on histology, lab report on biomarkers, prescription on current medications), then recency, then confidence. Conflicts that cannot be safely auto-resolved — HER2 IHC 2+ vs HER2 amplified, differing staging across visits — are surfaced to a verification UI and blocked from driving guideline selection until adjudicated. Values that are inferred AND low-confidence cannot drive downstream logic until verified.
Verified by a Case Manager, not the patient themselves.
A Case Manager reviews every extracted value against the source records before the case reaches you. Completeness is a precondition, not an afterthought — cancer-specific playbooks flag missing required documents before the case is routed.
The AI here works for the specialist, not in place of the specialist. The clinical reasoning, and the signed opinion that follows, is entirely yours.
The second-opinion category in India covers directories, teleconsultations, and multi-week treatment-planning services. The structural distinction is what is done to the case before it reaches you, who decides where it goes, and how quickly the whole thing moves.
Structured first, then routed.
Before the case reaches you, our Clinical Intelligence layer extracts and structures every relevant field — diagnosis, histology, TNM staging, biomarkers, treatment history, imaging findings — and a Case Manager verifies each value against the source records. You receive a structured clinical case file with source-linking, confidence tagging, and conflict adjudication already done. Most other second-opinion services skip this layer entirely; the specialist is expected to do the reading and structuring during the consultation itself.
Routed by clinical fit, not by availability.
Once structured, our Matchmaking Intelligence layer routes the case using your DMG, sub-specialty focus, and case-type declarations from onboarding. You receive cases that fit your clinical interest — not cases that happen to land at a moment you were free. This is what protects both the clinical quality of the opinion and your time as a specialist. The platform never routes a case to a generalist or to a sub-specialty mismatch in the interest of speed.
Often faster than 48 hours.
Because the first two layers have done their work, the reading and writing of the opinion is the smallest part of the case lifecycle. Our committed turnaround is 48 hours; in practice, the majority of cases are completed sooner. For genuinely rare or extremely complex cases, deeper-analysis platforms exist, and we are honest that the path is longer there. We are building toward serving those cases at the same pace; we are not there yet.
We are filling a specific position in the category, not competing with it — and the architecture is what makes the position defensible.